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1,3,4-Oxadiazole is apparently among the most signiﬁcant
heterocyclic cores. The 1,3,4-oxadiazole derivatives may act
as ester and amide bioisosteres and hence are of interest in
pharmaceutical and agrochemical ﬁelds (Zarudnitskii et al.,
2008). The wide range of biological activities associated with
1,3,4-oxadiazoles include anti-viral (Tan et al., 2006),37362212.
(N.N. Farshori).
Saud University.
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ntimicrobial activities. Arabian Journaantimicrobial (Mayekar, 2010), antineoplastic (Aboraia
et al., 2006), fungicidal (Li et al., 2006), inhibition of tyrosinase
(Khan et al., 2005) and cathepsin K (Palmer et al., 2006). Also,
much attention has been focused on the oxadiazole coreP-sys-
tems as electron-transporting and hole-blocking materials in
the area of organic light-emitting diodes (OLEDs) (He et al.,
2008). Further 1,3,4-oxadiazole heterocycles can contribute
substantially in increasing the pharmacological activity by par-
ticipating in hydrogen bonding interactions with the receptors
(Guimaraes et al., 2005).
Several methods have been reported in the literature for the
synthesis of 1,3,4-oxadiazoles (Coppo et al., 2004; Brain and
Brunton, 2001). Most of these protocols are multi-step in nat-
ure and generally involve the cyclization of acid hydrazides
with a variety of reagents, such as, phosphorus oxy chloride,ing Saud University.
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2 N.N. Farshori et al.sulfuric acid and thionyl chloride, usually under harsh condi-
tions. Recently a few efﬁcient examples have been reported
for the synthesis of 1,3,4-oxadiazoles, especially from readily
available carboxylic acids and acid hydrazides. However, these
protocols use expensive catalysts and require longer times for
the completion of the reaction (Dolman et al., 2006; Jakopin
et al., 2007). Consequently, the development of effective meth-
ods for the rapid and concise synthesis and modiﬁcation of
oxadiazole motif need to be developed.
The application of microwave irradiation in organic synthe-
sis for conducting reactions at highly accelerated rates is an
emerging technique (Loupy, 2004). In fact, in recent years,
the use of microwaves have become popular among synthetic
organic chemists both to improve classical organic reactions
(shortening reaction times and/or improving yields) as well
as to promote new reactions.
The substantial reduction in the reaction times under
microwave irradiation and the pharmacological importance
of 1,3,4-oxadiazole ring systems prompted us to synthesize
the 2,5-disubstituted-1,3,4-oxadiazoles bearing an alkanyl/
alkenyl/hydroxyalkenyl chain substituent and evaluate them
for their antimicrobial activity. To the best of our awareness
this contribution reports for the ﬁrst time the simple and
straightforward synthesis of 1,3,4-oxadiazoles under micro-
wave condition having a long chain substituent.2. Experimental
2.1. Chemistry
Undec-10-enoic (purity 98%), (9Z)-octadec-9-enoic (97%),
benzoic acid and chlorobenzoic acids were purchased from
Fluka chemicals (Bucks, Switzerland). (9Z,12R)-12-Hydroxy-
octadec-9-enoic (ricinoleic) and (9R,12Z)-9-hydroxyoctadec-
12-enoic (isoricinoleic) acids were isolated from the natural
sources, i.e. from Ricinus communis and Wrightia tinctoria
seed oils, respectively. The concentrate of pure hydroxy acids
were obtained by Gunstone’s partitioning (Gunstone, 1954)
of freshly prepared acids and further puriﬁed by column chro-
matography. 1H NMR and 13C NMR spectra were recorded in
CDCl3 on a Bruker DRX-400 instrument. The chemical shifts
(d) were measured relative to TMS as an internal standard.
Coupling constants (J) are expressed in Hz. Mass spectra were
obtained on a Jeol SX-102 (FAB) spectrometer. IR spectra
were obtained on Shimadzu 8201 PC FTIR using KBr pellet
with absorption given in cm1. The microwave irradiations
were carried out using a modiﬁed domestic microwave oven
(LG, 2.45 GHz, 850 W). Brieﬂy, the modiﬁed microwave oven
consists of a perforation on the top to accommodate a reﬂux
condenser and a 10-cm stainless steel cylinder to avoid leakage
of microwave energy. In addition to this the turnable was re-
placed with the magnetic stirrer and a temperature detector
was added.
2.1.1. General procedure for the synthesis of fatty acid
hydrazides (1a–d)
The hydrazides of long chain alkenoic acids (1a–d) used as the
starting material were prepared by previously reported method
(Rauf et al., 2007). The synthesized hydrazides were character-
ized by their melting points.Please cite this article in press as: Farshori, N.N. et al., A facile one-pot synthesis o
conditions and evaluation of their in vitro antimicrobial activities. Arabian Journ2.1.2. General procedure for the conventional synthesis of 2,5-
disubstituted-1,3,4-oxadiazoles(3a–l)
Phosphorus oxy chloride (5 ml) was added to a mixture of
substituted carboxylic acid (0.01 mol) and fatty acid hydrazide
(0.01 mol) in abs. ethanol. The reaction mixture was reﬂuxed
for 8–14 h on a water bath. After the completion of the reac-
tion, the contents were cooled at room temperature and
poured into crushed ice. The precipitated crude product was
washed with 10% solution of NaHCO3 and further recrystal-
lized from 95% ethanol (Table 1).
2.1.3. General procedure for the synthesis of 2,5-disubstituted-
1,3,4-oxadiazoles (3a–l) under solvent-free microwave
conditions
A mixture of fatty acid hydrazide (0.01 mol), carboxylic acid
(0.01 mol) and alumina (1.50 g) wasmixed and ground in amor-
tar and pestle until a ﬁne homogenous powder was obtained
(5 min). Phosphorus oxy chloride (5 ml)was added. Themixture
was irradiated under microwave irradiation for the required
time (Table 3). After the completion of the reaction (TLC anal-
ysis), ice cold water (10 ml) was added to the reaction mixture
and the precipitated crude product was ﬁltered. The crude
1,3,4-oxadiazole was washed with 10% solution of NaHCO3
and further puriﬁed by column chromatography over silica gel
using petroleum ether-diethyl ether mixture as eluent.
The synthesized 2,5-disubstituted-1,3,4-oxadiazoles (3a–l)
were characterized from their spectral data (IR, 1H NMR,
13C NMR and mass spectra).
2.1.4. 2-(Dec-90-enyl)-5-(furan-2-yl)-1,3,4-oxadiazole (3a)
IR (KBr, cm1): 1668 (C‚C), 1568 (C‚N), 1240 (C–O–C).
1H NMR (CDCl3, dH): 7.64 (m, 1H, furan 500-H), 7.32 (m,
1H, furan 200-H), 6.55 (m, 1H, furan 400-H), 5.82 (tdd, 1H,
J
H9 CH2 = 6.6 Hz, JHHZ = 10.2 Hz, JHHE = 17.0 Hz, CH2-
‚CHA), 5.01 (dd, 1H, JHZH = 11.8 Hz, JHZHE = 1.9 Hz,
HZC‚CH), 4.94 (dd, 1H, JHEH = 16.7 Hz,
JHEHZ = 2.2 Hz, HEC‚CHA), 2.36 (t, 2H, J= 7.4 Hz,
CH2 a to ring), 2.02 (m, 2H, CH2‚CH–CH2), 1.64 (m, 2H,
CH2 b to ring), 1.40-1.25 (br, s, 10H, (CH2)5).
13C NMR
(CDCl3, dC): 172.4, 168.2, 142.7, 139.4, 139.0, 114.7, 111.6,
40.2, 39.8, 38.3, 37.9, 31.3, 29.7, 28.4, 26.8. ESI-MS: found
[M+Na]+ 297.08; requires 297.12.
2.1.5. 2-[(80Z)-Heptadecenyl]-5-(furan-2-yl)-1,3,4-oxadiazole
(3b)
IR (KBr, cm1): 1666 (C‚C), 1561 (C‚N), 1245 (C–O–C).
1H NMR (CDCl3, dH): 7.68 (m, 1H, furan 500-H), 7.35 (m,
1H, furan 200-H), 6.51 (m, 1H, furan 400-H), 5.36 (m, 2H,
CH2ACH‚CHACH2), 2.31 (t, 2H, J= 7.4 Hz, CH2 a to
ring), 2.05 (m, 4H, CH2-CH‚CHACH2), 1.66 (m, 2H, CH2
b to ring), 1.28 (br, s, 20H, (CH2)10), 0.85 (dist. t, 3H, terminus
CH3).
13C NMR (CDCl3, dC): 172.4, 168.3, 142.6, 131.6, 125.3,
111.7, 40.9, 40.5, 38.6, 38.3, 33.6, 32.7, 31.8, 30.5, 29.8, 28.7,
28.4, 21.9, 20.6, 20.3, 14.0. ESI-MS: found [M+Na]+
395.11; requires 395.19.
2.1.6. (80Z,110R)-2-(110-Hydroxy-octadec-80-enyl)-5-(furan-2-
yl)-1,3,4-oxadiazole (3c)
IR (KBr, cm1): 3358 (OH), 1668 (C‚C), 1554 (C‚N), 1247
(C–O–C). 1H NMR (CDCl3, dH): 7.61 (m, 1H, furan 500-H),f novel 2,5-disubstituted-1,3,4-oxadiazoles under conventional and microwave
al of Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.010
Table 1 2,5-Disubstituted-1,3,4-oxadiazoles 3a–l.
Entry R R1 Product Time (h.) Yield (%)
1
CH2
H
H
6
z
E O
3a 10 82
2
CH2
56 O
3b 11 84
3
OH
CH2
4 5 O
3c 14 78
4
3
OH
CH2
6 O
3d 14 79
5
CH3 CH2
11 O
3e 8 86
6
CH3
H
Br
11
O
3f 8 85
7
CH2
H
H
6
z
E
Cl
3g 11 80
8
CH2
56
Cl
3h 12 82
9
OH
CH2
4 5
Cl
3i 13 75
10
3
OH
CH2
6
Cl
3j 14 78
11
CH3 CH2
11
Cl
3k 9 85
12
CH3
H
Br
11
Cl
3l 9 83
A facile one-pot synthesis of novel 2,5-disubstituted-1,3,4-oxadiazoles 37.28 (m, 1H, furan 200-H), 6.53 (m, 1H, furan 400-H), 5.37 (m,
2H, CH2ACH‚CHACH2), 3.69 (m, 1H, CH–OH), 2.38 (t,
2H, J= 7.5 Hz, CH2 a to ring), 2.10 (m, 1H, CH–OH), 1.96
(m, 4H, CH2ACH‚CHACH2), 1.58 (m, 2H, CH2 b to ring),
1.28 (br, s, 18H, (CH2)9), 0.86 (dist. t, 3H, terminus CH3).
13C NMR (CDCl3, dC): 172.3, 168.6, 142.8, 131.1, 124.9,
111.8, 70.5, 40.3, 38.9, 38.6, 31.5, 31.3, 29.0, 28.9, 28.3, 27.9,
27.3, 26.4, 26.1, 22.6, 14.2. ESI-MS: found [M+Na]+
411.17; requires 411.18.2.1.7. (80R,110Z)-2-(80-Hydroxy-octadec-110-enyl)-5-(furan-2-
yl)-1,3,4-oxadiazole (3d)
IR (KBr, cm1): 3353 (OH), 1669 (C‚C), 1557 (C‚N), 1251
(C–O–C). 1H NMR (CDCl3, dH): 7.63 (m, 1H, furan 500-H),
7.30 (m, 1H, furan 200-H), 6.55 (m, 1H, furan 400-H), 5.36 (m,
2H, CH2ACH‚CHACH2), 3.65 (m, 1H, CH–OH), 2.36 (t,
2H, J= 7.5 Hz, CH2 a to ring), 2.08 (m, 1H, CH–OH), 1.98
(m, 4H, CH2ACH‚CHACH2), 1.54 (m, 2H, CH2 b to ring),
1.30 (br, s, 18H, (CH2)9), 0.88 (dist. t, 3H, terminus CH3).
13C NMR (CDCl3, dC): 172.5, 168.1, 142.7, 131.9, 125.1,
111.1, 70.6, 40.3, 38.7, 38.3, 31.7, 31.6, 29.5, 28.7, 28.4, 27.6,Please cite this article in press as: Farshori, N.N. et al., A facile one-pot synthesis o
conditions and evaluation of their in vitro antimicrobial activities. Arabian Journa27.4, 26.8, 26.3, 22.5, 14.1. ESI-MS: found [M+Na]+
411.17; requires 411.18.
2.1.8. 2-Pentadec-5-(furan-2-yl)-1,3,4-oxadiazole (3e)
IR (KBr, cm1): 1667 (C‚C), 1571 (C‚N), 1249 (C–O–C).
1H NMR (CDCl3, dH): 7.63 (m, 1H, furan 500-H), 7.32 (m,
1H, furan 200-H), 6.54 (m, 1H, furan 400-H), 2.36 (t, 2H,
J= 7.4 Hz, CH2 a to ring), 1.69 (m, 2H, CH2 b to ring),
1.25 (br, s, 24H, (CH2)12), 0.87 (dist. t, 3H, terminus CH3).
13C NMR (CDCl3, dC): 172.1, 168.2, 142.2, 111.7, 40.6, 40.4,
40.2, 40.0, 39.8, 39.6, 33.9, 33.7, 29.2, 28.9, 28.7, 26.4, 25.4,
25.1, 14.0. ESI-MS: found [M+Na]+ 369.15; requires 369.17.
2.1.9. 2-[1-Bromopentadec]-5-(furan-2-yl)-1,3,4-oxadiazole
(3f)
IR (KBr, cm1): 1665 (C‚C), 1569 (C‚N), 1248 (C–O–C),
558 (C–Br). 1H NMR (CDCl3, dH): 7.65 (m, 1H, furan 500-
H), 7.33 (m, 1H, furan 200-H), 6.56 (m, 1H, furan 400-H), 2.38
(t, 2H, J= 7.4 Hz, CH2 a to ring), 1.65 (m, 2H, CH2 b to
ring), 1.29 (br, s, 24H, (CH2)12), 0.87 (dist. t, 3H, terminus
CH3).
13C NMR (CDCl3, dC): 172.5, 168.5, 143.0, 111.6,f novel 2,5-disubstituted-1,3,4-oxadiazoles under conventional and microwave
l of Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.010
R
NH
O
NH2
+ R1
OH
O POCl3
Reflux O
N N
R R1
1a-f 2a-b 3a-l
Scheme 1 Conventional synthesis of 2,5-disubstituted-1,3,4-
oxadiazoles 3a–l.
4 N.N. Farshori et al.52.1, 40.7, 40.5, 40.1, 39.2, 38.9, 34.0, 33.3, 29.0, 28.7, 28.1,
26.3, 24.9, 25.5, 14.1. ESI-MS: found [M+Na]+ 448.04; re-
quires 448.07.
2.1.10. 2-(Dec-90-enyl)-5-(chlorobenzene-2-yl)-1,3,4-
oxadiazole (3g)
IR (KBr, cm1): 1665 (C‚C), 1563 (C‚N), 1242 (C–O–C),
748 (C–Cl). 1H NMR (CDCl3, dH): 7.99 (m, 1H, Ar-H-300),
7.47 (m, 2H, Ar-H-400/500), 7.34 (m, 1H, Ar-H-600), 5.80 (tdd,
1H, J
H9 CH2 = 6.6 Hz, JHHZ = 10.2 Hz, JHHE = 16.9 Hz,
CH2‚CHA), 4.98 (dd, 1H, JHZH = 11.8 Hz, JHZHE =
1.9 Hz, HZC‚CH), 4.93 (dd, 1H, JHEH = 16.7 Hz,
JHEHZ = 2.2 Hz, HEC‚CHA), 2.35 (t, 2H, J= 7.4 Hz, CH2
a to ring), 2.02 (m, 2H, CH2‚CHACH2), 1.63 (m, 2H, CH2
b to ring), 1.29-1.40 (br, s, 10H, (CH2)5).
13C NMR (CDCl3,
dC): 172.9, 168.4, 139.6, 131.4, 128.7, 128.3, 125.8, 122.6,
114.3, 40.1, 39.7, 38.6, 37.4, 32.0, 29.5, 28.6, 26.6. ESI-MS:
found [M+Na]+ 341.5; requires 341.6.
2.1.11. 2-[(80Z)-Heptadecenyl]-5-(chlorobenzene-2-yl)-1,3,4-
oxadiazole (3h)
IR (KBr, cm1): 1667 (C‚C), 1562 (C‚N), 1248 (C–O–C),
743 (C–Cl). 1H NMR (CDCl3, dH): 7.98 (m, 1H, Ar-H-300),
7.46 (m, 2H, Ar-H-400/500), 7.33 (m, 1H, Ar-H-600), 5.34 (m,
2H, CH2ACH‚CHACH2), 2.33 (t, 2H, J= 7.4 Hz, CH2 a
to ring), 2.03 (m, 4H, CH2ACH‚CHACH2), 1.62 (m, 2H,
CH2 b to ring), 1.26 (br, s, 20H, (CH2)10), 0.87 (dist. t, 3H, ter-
minus CH3).
13C NMR (CDCl3, dC): 172.4, 168.3, 131.6, 131.4,
128.9, 128.6, 125.7, 125.3, 122.2, 40.9, 40.5, 38.6, 38.3, 33.6,
32.7, 31.8, 30.5, 29.8, 28.7, 21.9, 20.6, 20.3, 14.0. ESI-MS:
found [M+Na]+ 439.65; requires 439.67.
2.1.12. (80Z,110R)-2-(110-Hydroxy-octadec-80-enyl)-5-
(chlorobenzene-2-yl)-1,3,4-oxadiazole (3i)
IR (KBr, cm1): 3352 (OH), 1665 (C‚C), 1569 (C‚N), 1243
(C–O–C), 745 (C–Cl). 1H NMR (CDCl3, dH): 7.90 (m, 1H,
Ar-H-300), 7.42 (m, 2H, Ar-H-400/500), 7.29 (m, 1H, Ar-H-600),
5.27 (m, 2H, CH2ACH‚CHACH2), 3.58 (m, 1H, CH–OH),
2.34 (t, 2H, J= 7.4 Hz, CH2 a to ring), 2.09 (m, 1H,
CH–OH), 1.98 (m, 4H, CH2ACH‚CHACH2), 1.56 (m, 2H,
CH2 b to ring), 1.25 (br, s, 18H, (CH2)9), 0.81 (dist. t, 3H, ter-
minus CH3).
13C NMR (CDCl3, dC): 172.4, 168.3, 131.6, 131.1,
128.6, 128.5, 125.9, 125.2, 122.6, 70.1, 40.2, 38.5, 37.9, 31.8,
31.1, 29.3, 28.7, 27.4, 27.0, 26.3, 26.0, 22.5, 14.1. ESI-MS:
found [M+Na]+ 455.62; requires 455.66.
2.1.13. (80R,110Z)-2-(80-Hydroxy-octadec-110-enyl)-5-
(chlorobenzene-2-yl)-1,3,4-oxadiazole (3j)
IR (KBr, cm1): 3353 (O–H), 1667 (C‚C), 1565 (C‚N), 1244
(C–O–C), 741 (C–Cl). 1H NMR (CDCl3, dH): 7.91 (m, 1H,
Ar-H-300), 7.40 (m, 2H, Ar-H-400/500), 7.27 (m, 1H, Ar-H-600),
5.29 (m, 2H, CH2ACH‚CHACH2), 3.56 (m, 1H, CH–OH),
2.30 (t, 2H, J= 7.4 Hz, CH2 a to ring), 2.11 (m, 1H,
CH–OH), 1.95 (m, 4H, CH2ACH‚CHACH2), 1.57 (m, 2H,
CH2 b to ring), 1.22 (br, s, 18H, (CH2)9), 0.81 (dist. t, 3H,
terminus CH3).
13C NMR (CDCl3, dC): 172.6, 168.7, 131.9,
131.1, 128.6, 128.3, 125.5, 125.2, 122.1, 70.1, 40.6, 38.5,
37.5, 31.8, 31.0, 29.3, 28.1, 27.4, 27.0, 26.9, 26.5, 22.5, 14.1.
ESI-MS: found [M+Na]+ 455.62; requires 455.66.Please cite this article in press as: Farshori, N.N. et al., A facile one-pot synthesis o
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(3k)
IR (KBr, cm1): 1663 (C‚C), 1565 (C‚N), 1244 (C–O–C),
743 (C–Cl). 1H NMR (CDCl3, dH): 8.00 (m, 1H, Ar-H-300),
7.47 (m, 2H, Ar-H-400/500), 7.34 (m, 1H, Ar-H-600), 2.35 (t,
2H, J= 7.4 Hz, CH2 a to ring), 1.64 (m, 2H, CH2 b to ring),
1.27 (br, s, 24H, (CH2)12), 0.87 (dist. t, 3H, terminus CH3).
13C
NMR (CDCl3, dC): 172.2, 168.1, 131.3, 128.7, 128.5, 125.9,
122.3, 40.3, 40.1, 40.0, 39.6, 39.3, 33.5, 33.0, 29.1, 28.3, 26.9,
25.1, 25.0, 14.0. ESI-MS: found [M+Na]+ 413.64; requires
413.65.
2.1.15. 2-[1-Bromopentadec]-5-(chlorobenzene-2-yl)-1,3,4-
oxadiazole (3l)
IR (KBr, cm1): 1668 (C‚C), 1569 (C‚N), 1249 (C–O–C),
748 (C–Cl), 552 (C–Br). 1H NMR (CDCl3, dH): 8.00 (m, 1H,
Ar-H-300), 7.47 (m, 2H, Ar-H-400/500), 7.35 (m, 1H, Ar-H-600),
2.37 (t, 2H, J= 7.4 Hz, CH2 a to ring), 1.66 (m, 2H, CH2 b
to ring), 1.26 (br, s, 24H, (CH2)12), 0.88 (dist. t, 3H, terminus
CH3).
13C NMR (CDCl3, dC): 172.5, 168.3, 131.5, 128.6, 128.3,
125.6, 122.7, 52.4, 40.6, 40.4, 39.9, 39.2, 37.9, 34.6, 33.1, 29.6,
28.7, 28.0, 26.4, 24.6, 25.1, 14.0. ESI-MS: found [M+Na]+
492.53; requires 492.55.
2.2. Determination of antibacterial activity
The newly prepared compounds were screened for their anti-
bacterial activity against Escherichia coli (ATCC-25922),
Methicillin resistant Staphylococcus aureus (MRSA +Ve),
Pseudomonas aeruginosa (ATCC-27853), Streptococcus pyogenes
and Klebsiella pneumoniae (Clinical isolate) bacterial strains by
disc diffusion method (Cruickshank et al., 1975; Collins, 1976).
Ciproﬂoxacin (30 lg) was used as positive control. While the
disk immersed in DMSO was used as negative control. The
susceptibility was assessed on the basis of the diameter of zone
of inhibition against Gram-positive and Gram-negative strains
of bacteria. Inhibition zones were measured and compared
with the controls. The bacterial zones of inhibition values
are given in Table 4.
Minimum inhibitory concentrations (MICs) were deter-
mined by broth dilution technique. The lowest concentration
(highest dilution) required to arrest the growth of bacteria
was regarded as minimum inhibitory concentration (MIC).
MBC was deﬁned as the lowest drug concentration at which
99.9% of the inoculums were killed. The minimum inhibitory
concentrations and minimum bactericidal concentrations are
given in Table 5.
2.3. Determination of antifungal activity
Antifungal activity was also determined by disk diffusion
method. For assaying antifungal activity Candida albicans,f novel 2,5-disubstituted-1,3,4-oxadiazoles under conventional and microwave
al of Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.010
A facile one-pot synthesis of novel 2,5-disubstituted-1,3,4-oxadiazoles 5Aspergillus fumigatus, Penicillium marneffei and Trichophyton
mentagrophytes (recultured) in DMSO were tested by agar dif-
fusion method (Khan, 1997; Varma, 1998). The fungal activity
of each compound was compared with Greseofulvin as stan-
dard drug. Inhibition zones were measured and compared with
the controls. The fungal zones of inhibition values are given in
Table 6. The lowest concentration (highest dilution) required
to arrest the growth of fungus was regarded as minimum inhib-
itory concentration (MIC). MFC was deﬁned as the lowest
drug concentration at which 99.9% of the inoculums were
killed. The minimum inhibitory concentrations and minimum
fungicidal concentrations are given in Table 7.
3. Results and discussion
3.1. Chemistry
Due to the beneﬁcial pharmacological properties of certain
molecules containing 1,3,4-oxadiazole moiety the synthesis of
new 1,3,4-oxadiazole derivatives using procedures in which
some aspect of green chemistry could be met is desirable.
Our main strategy in this work was to synthesize new 1,3,4-
oxadiazole derivatives with potential biological activities, using
microwave-induced organic reaction enhancement methodol-
ogy, which is extremely fast, cleaner than conventional reac-
tions and lead to a higher atom economy (less chemical waste).
The conventional synthesis of the target 2,5-disubstituted-
1,3,4-oxadiazoles (3a–l) was achieved by reﬂuxing a mixture
of fatty acid hydrazide (1a–f) and appropriate carboxylic acid
(2a–b) in presence of phosphorus oxy chloride (Scheme 1). The
product yields and the reaction times required for the comple-
tion of the reaction under reﬂux conditions are given in
Table 1. As, can be seen from Table 1, the reaction time ranged
within 8–14 h.
Further to explore the probability of getting the pharmaco-
phoric important moiety in higher yields and in shorter reac-
tion times, our attention turned toward employing the
microwave irradiation. The application of microwave energy
to organic compounds for conducting synthetic reactions at
highly accelerated rates is an emerging technique. In fact, in re-
cent years, microwave has become popular among synthetic
organic chemists both to improve classical organic reactions,
shortening reaction times and/or improving yields, as well as
to promote new reactions. Under microwave conditions, the
reactions were carried out by irradiating a mixture of fatty acid
hydrazide (1a–f) with the appropriate carboxylic acid (2a–b),
supported on neutral alumina, using phosphorus oxy chloride
as the cyclizing agent (Scheme 2).
At ﬁrst, the condensation reaction of hydrazide of undec-
10-enoic acid (1a) with 2-furoic acid (2a) was chosen as a mod-
el to optimize the conditions for the preparation of compounds
3a–l (Table 2). In order to determine the optimum conditionsR
NH
O
NH2
+ R1
OH
O
O
N N
R R1
POCl3, Al2O3
MW
1a-f 2a-b 3a-l
Scheme 2 Synthesis of 2,5-disubstituted-1,3,4-oxadiazoles (3a–l)
under microwave irradiation.
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reagents, the microwave irradiation time and the power level
of microwave setup were investigated.
After some experimentation, we found a set of conditions
that generally provided the products in good yields. The opti-
mum conditions were set up and the target 2,5-disubstituted-
1,3,4-oxadiazoles (3a–l) were synthesized in appreciable yields
(Table 3).
As per our requirement, the strategy successfully worked
out. All the reactions proceeded in shorter reaction time and
an appreciable increment in the product yield was observed
as compared to conventional reaction conditions. The general-
ity and ability of this methodology in the synthesis of 2,5-
disubstituted-1,3,4-oxadiazoles were demonstrated by using a
variety of structurally divergent fatty acid hydrazides and car-
boxylic acids. The scope of the reaction using saturated, oleﬁn
(internal and terminal) and hydroxy fatty acid hydrazides was
found to be good. Moreover, the nature of hydrazide and the
carboxylic acid did not show strongly obvious effects in terms
of yields. The synthesized compounds were characterized by
IR, 1H NMR, 13C NMR and mass spectral analysis.
The spectra of compound 3a showed IR absorption bands
at 1668, 1568, 1240 cm1 due to C‚C, C‚N and C–O–C
functions. The 1H NMR was more informative in assigning
the structure. Diagnostic peaks at d 7.64, 7.32 and 6.55 were
observed for the furan ring system. A triplet at d 2.36 was ob-
served for the methylene protons a to the oxadiazole ring. The
methine proton of C-9 showed a signal at 5.82. The C-10 meth-
ylene protons designated as HE and HZ displayed two distinct
d values when coupled with adjacent C-9 methine protons.
Thus, the 1H NMR showed two doublet of doublet at d 5.01
and 4.94 for HZ and HE protons, respectively. In the
13C
NMR peaks at d 172.4 and 168.2 were observed for the ring
carbon atoms. The mass spectrum was also consistent with
the assigned molecular formula.
Similarly, the spectra of compound 3g showed the IR
absorption bands at 1665, 1563, 1242 cm1 due to C‚C,
C‚N and C–O–C functions. A characteristic IR band at
748 cm1 was also observed for the aromatic ring system.
The 1H NMR was more informative in assigning the structure.
Diagnostic peaks at d 7.98, 7.46 and 7.33 were observed for the
aromatic ring system. A triplet at 2.35 was observed for the
methylene protons a to the oxadiazole ring. The methine pro-
ton of C-9 showed a signal at 5.80. The C-10 methylene pro-
tons designated as HE and HZ displayed two distinct d
values when coupled with adjacent C-9 methine protons. Thus,
the 1H NMR showed two doublet of doublet at d 4.98 and 4.93
for HZ and HE protons, respectively. The
13C NMR showed
characteristic peaks at d 172.9 and 168.4 for the oxadiazole
ring carbon atoms. The mass spectrum was also consistent
with the assigned molecular formula Detailed spectral data
of the titled compounds are given in the experimental section.
3.2. Antibacterial studies
The newly prepared compounds were screened for their anti-
bacterial activity against E. coli (ATCC-25922), Methicillin
resistant S. aureus (MRSA +Ve), P. aeruginosa (ATCC-
27853), S. pyogenes and K. pneumoniae (Clinical isolate) bacte-
rial strains by disc diffusion method (Mayekar, 2010; Palmer
et al., 2006). Ciproﬂoxacin (30 lg) was used as positivef novel 2,5-disubstituted-1,3,4-oxadiazoles under conventional and microwave
l of Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.010
Table 2 Optimization of the microwave-assisted condensation of 1a and 2a on neutral alumina.
NH
Hz
H
O
NH2
HE
+
O
OH
O
O
N N
O
Hz
HHE
POCl3, Al2O3
MW
1a 2a 3a
Entry Support Molar ratio (1a/2a) Time (min.) Power (%) Yield (%)
1 Neutral alumina 0.2/0.5 5 30 45
2 Neutral alumina 0.5/0.8 7 40 52
3 Neutral alumina 0.8/1.0 12 50 71
4 Neutral alumina 1.0/1.0 16 60 90
Table 3 2,5-Disubstituted-1,3,4-oxadiazoles (3a–l) under microwave conditions.
Entry 1 2 1/2a Power (%)b Time (h.)c Product Yield (%)d
1 1a 2a 1/1 60 16 3a 90
2 1b 2a 1/1 60 16 3b 90
3 1c 2a 1/1 60 17 3c 85
4 1d 2a 1/1 60 17 3d 87
5 1e 2a 1/1 60 15 3e 92
6 1f 2a 1/1 60 15 3f 93
7 1a 2b 1/1 60 19 3g 89
8 1b 2b 1/1 60 19 3h 90
9 1c 2b 1/1 60 20 3i 86
10 1d 2b 1/1 60 20 3j 88
11 1e 2b 1/1 60 18 3k 91
12 1f 2b 1/1 60 17 3l 91
a All reactions were carried out using fatty acid hydrazides (1 eq) with respect to carboxylic acids and POCl3 under microwave irradiation.
b Microwave equipment multimode was used.
c Monitored by TLC.
d All yields refer to isolated products and the products were characterized by IR, 1H NMR, 13C NMR and mass spectral analysis.
Table 4 Antibacterial activity of 2,5-disubstituted-1,3,4-oxadiazoles 3a–l.
Compounds Diameter of zone of inhibition (mm)
Gram positive bacteria Gram negative bacteria
S. pyogenes MRSAc P. aeruginosa K. pneumoniae E. coli
3a 11.4 ± 0.4 11.1 ± 0.3 13.2 ± 0.2 11.5 ± 0.3 12.1 ± 0.4
3b 21.3 ± 0.4 20.8 ± 0.3 23.4 ± 0.2 19.4 ± 0.5 20.9 ± 0.4
3c 19.1 ± 0.5 18.3 ± 0.4 21.1 ± 0.4 17.1 ± 0.5 18.5 ± 0.3
3d 13.4 ± 0.4 13.2 ± 0.4 16.1 ± 0.6 13.6 ± 0.2 14.3 ± 0.2
3e 16.2 ± 0.4 15.5 ± 0.2 13.2 ± 0.3 15.5 ± 0.4 16.5 ± 0.3
3f 22.5 ± 0.2 21.6 ± 0.4 27.3 ± 0.6 22.5 ± 0.2 23.4 ± 0.5
3g 14.5 ± 0.4 14.4 ± 0.4 16.1 ± 0.6 13.6 ± 0.2 14.3 ± 0.2
3h 17.1 ± 0.2 16.6 ± 0.3 14.1 ± 0.4 15.5 ± 0.4 16.5 ± 0.3
3i 20.1 ± 0.3 19.5 ± 0.2 22.2 ± 0.3 18.2 ± 0.3 19.6 ± 0.2
3j 20.2 ± 0.4 19.7 ± 0. 3 22.3 ± 0. 2 18.3 ± 0.5 19.8 ± 0.4
3k 12.4 ± 0.5 12.1 ± 0.5 14.2 ± 0.4 11.7 ± 0.5 12.1 ± 0.5
3l 21.4 ± 0.3 20.5 ± 0.4 26.2 ± 0.4 21.4 ± 0.4 22.3 ± 0.4
Standard 23.0 ± 0.2 22.0 ± 0.2 32.0 ± 0.3 19.0 ± 0.2 27.0 ± 0.2
DMSO – – – – –
aPositive control (standard) Ciproﬂoxacin and negative control (DMSO), bMeasured by the Halo Zone Test (Unit, mm), cMethicillin resistant
Staphylococcus aureus (MRSA +Ve).
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Table 5 MIC and MBC results of 2,5-disubstituted-1,3,4-oxadiazoles 3a–l.
Compounds Gram positive bacteria Gram negative bacteria
S. pyogenes MRSAd P. aeruginosa K. pneumoniae E.coli
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
3a 50 100 50 >100 50 >100 100 >100 100> 100
3b 25 50 12.5 50 12.5 50 50 100 25 100
3c 25 100 25 50 25 100 50 50 25 100
3d 50 100 50 100 50 100 50 100 50 >100
3e 25 100 50 100 25 100 25 100 50 100
3f 12.5 25 12.5 50 12.5 50 12.5 50 12.5 50
3g 50 100 50 100 50 100 25 100 50 >100
3h 25 100 25 50 25 100 25 100 50 100
3i 25 100 25 50 12.5 100 25 50 25 100
3j 25 50 12.5 25 12.5 50 25 100 25 100
3k 50 100 50 >100 100 >100 100 >100 100 >100
3l 12.5 25 12.5 25 12.5 25 12.5 50 12.5 50
Standard 12.5 12.5 6.25 12.5 12.5 25 6.25 25 6.25 12.5
aPositive control Ciproﬂoxacin. bMIC (lg/ml) = minimum inhibitory concentration, i.e., the lowes concentration of the compound to inhibit
the growth of bacteria completely; cMBC (lg/ml) = minimum bacterial concentration, i.e., the lowest concentration of the compound for killing
the bacteria completely. dMethicillin resistant Staphylococcus aureus (MRSA +Ve).
Table 6 Antifungal activity of 2,5-disubstituted-1,3,4-oxadi-
azoles 3a–l.
Compounds Diameter of zone of inhibition (mm)
CA AF TM PM
3a 19.9 ± 0.3 18.5 ± 0.5 16.4 ± 0.2 11.9 ± 0.3
3b 26.1 ± 0.3 21.1 ± 0.2 18.3 ± 0.3 13.7 ± 0.2
3c 23.1 ± 0.3 20.2 ± 0.5 16.7 ± 0.4 13.1 ± 0.4
3d 21.1 ± 0.3 18.5 ± 0.4 14.7 ± 0.5 13.2 ± 0.4
3e 22.8 ± 0.5 19.6 ± 0.6 17.1 ± 0.3 13.3 ± 0.6
3f 26.2 ± 0.4 21.6 ± 0.5 18.2 ± 0.4 14.1 ± 0.3
3g 22.2 ± 0.4 19.7 ± 0.3 15.8 ± 0.9 14.3 ± 0.2
3h 23.9 ± 0.6 20.7 ± 0.2 18.1 ± 0.2 14.3 ± 0.6
3i 24.1 ± 0.5 21.3 ± 0.3 17.8 ± 0.5 14.2 ± 0.9
3j 27.2 ± 0.4 22.1 ± 0.2 19.4 ± 1.2 14.8 ± 0.3
3k 21.3 ± 0.3 19.6 ± 0.4 16.4 ± 0.2 12.9 ± 0.3
3l 27.1 ± 0.3 22.7 ± 1.2 19.3 ± 0.7 15.1 ± 0.2
Standard 30.0 ± 0.2 27.0 ± 0.2 24.0 ± 0.3 20.0 ± 0.5
DMSO – – – –
aPositive control (Greseofulvin) and negative control (DMSO),
bMeasured by the Halo Zone Test (Unit, mm). cCA= Candida
albicans, dAF = Aspergillus fumigatus, eTM= Trichophyton
mentagrophytes, fPM= Penicillium marneffei.
A facile one-pot synthesis of novel 2,5-disubstituted-1,3,4-oxadiazoles 7control. While the disk immersed in DMSO was used as nega-
tive control. The susceptibility was assessed on the basis of the
diameter of zone of inhibition against Gram-positive and
Gram-negative strains of bacteria. Inhibition zones were mea-
sured and compared with the controls. The bacterial zones of
inhibition values are given in Table 4.
Minimum inhibitory concentrations (MICs) were deter-
mined by broth dilution technique. The lowest concentration
(highest dilution) required to arrest the growth of bacteria
was regarded as minimum inhibitory concentration (MIC).
MBC was deﬁned as the lowest drug concentration at which
99.9% of the inoculums were killed. The minimum inhibitory
concentrations and minimum bactericidal concentrations are
given in Table 5.Please cite this article in press as: Farshori, N.N. et al., A facile one-pot synthesis o
conditions and evaluation of their in vitro antimicrobial activities. Arabian JournaThe investigation of antibacterial screening data revealed
that all the tested compounds showed moderate to good bac-
terial inhibition. Good inhibitory results were obtained against
S. pyogenes, S. aureus and E. coli species. The structure activity
data showed that various substituted 1,3,4-oxadiazoles 3a–l
have varying degree of microbial inhibition. The antibacterial
activity seemed to be dependent on both substituents. The
presence of chlorobenzyl substituents at C-5 of the oxadiazole
ring system in compounds 3a–l was found to enhance the bac-
terial inhibition effects. Further, a marked enhancement in the
antibacterial activity was observed for the compounds bearing
a bromo or a hydroxy group in the long chain substituent at C-
2 of the oxadiazole moiety. The compounds 3c, 3d, 3f, 3i, 3j
and 3l showed good inhibition against S. pyogenes, S. aureus
and E. coli species. The oxadiazoles 3f, 3j and 3l showed activ-
ity nearly equivalent to that of Ciproﬂoxacin ranging from
21.6 ± 0.4 to 27.3 ± 0.6 for 3f, 18.3 ± 0.5 to 22.3 ± 0.2 for
3j and 20.5 ± 0.4 to 26.2 ± 0.4 for 3l. The MICs and MBCs
also revealed good antibacterial activity. The MBC in most
of the compounds was two or three or four fold higher than
the corresponding MIC results.3.3. Antifungal studies
Antifungal activity was also done by disk diffusion method.
For assaying the antifungal activity C. albicans, A. fumigatus,
P. marneffei and T. mentagrophytes (recultured) in DMSO
were tested by agar diffusion method (Rauf et al., 2007; Tan
et al., 2006). The fungal activity of each compound was com-
pared with Greseofulvin as standard drug. Inhibition zones
were measured and compared with the controls. The fungal
zones of inhibition values are given in Table 6. The lowest con-
centration (highest dilution) required to arrest the growth of
fungus was regarded as minimum inhibitory concentration
(MIC). MFC was deﬁned as the lowest drug concentration
at which 99.9% of the inoculums were killed. The minimum
inhibitory concentrations and minimum fungicidal concentra-
tions are given in Table 7.f novel 2,5-disubstituted-1,3,4-oxadiazoles under conventional and microwave
l of Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.010
Table 7 MIC and MFC of 2,5-disubstituted-1,3,4-oxadiazoles 3a–l.
Compounds CA AF TM PM
MIC MFC MIC MFC MIC MFC MIC MFC
3a 50 100 50 >100 50 100 50 >100
3b 12.5 25 25 50 25 50 25 100
3c 12.5 100 25 50 25 50 25 100
3d 25 100 50 100 25 >100 25 100
3e 25 100 25 100 25 100 25 100
3f 6.25 12.5 25 12.5 25 100 25 50
3g 25 100 50 100 25 100 25 100
3h 25 50 25 50 25 100 25 100
3i 12.5 50 25 50 25 50 25 100
3j 12.5 25 25 50 25 50 12.5 100
3k 50 100 50 100 50 100 50 100
3l 6.25 12.5 6.25 12.5 12.5 25 12.5 25
Standard 6.25 25 12.5 12.5 6.25 25 12.5 25
aCA= Candida albicans, bAF = Aspergillus fumigatus, cTM= Trichophyton mentagrophytes, dPM= Penicillium marneffei. eMIC (lg/
ml) = minimum inhibitory concentration, i.e the lowest concentration of the compound to inhibit the growth of fungus completely; fMFC (lg/
ml) = minimum fungicidal concentration, i.e., the lowest concentration of the compound for killing the fungus completely.
8 N.N. Farshori et al.The antifungal screening data showed moderate to good
activity. The 2,5-disubstituted-1,3,4-oxadiazoles 3a–l showed
same antifungal activity trends as for the bacterial strains.
Good inhibition results were obtained against C. albicans,
A. fumigatus and P. marneffei fungal strains. Moderate activity
was obtained in case of T. mentagrophytes fungal strains. The
compounds 3f, 3j and 3l were found to be the most potent anti-
fungal agents with the diameter of zone of inhibition ranging
from 14.1 ± 0.3 to 26.2 ± 0.4 for 3f, 14.8 ± 0.3 to
27.2 ± 0.4 for 3j and 15.1 ± 0.2 to 27.1 ± 0.3 for 3l. The
MFC of the synthesized compounds was two or three or four
fold higher than the corresponding MIC results, suggesting
that the newly synthesized compounds possess moderate to
good antifungal activity.
4. Conclusion
In conclusion we have developed a simple and efﬁcient method
for the synthesis of 2,5-disubstituted-1,3,4-oxadiazole bearing
an alkanyl/alkenyl/hydroxyalkenyl chain substituent. This pro-
tocol leads to a considerable reduction in reaction time and is
energetically proﬁtable. Some of the newly synthesized com-
pounds showed signiﬁcant anti-bacterial and anti-fungal activ-
ities. The diameter of zone of inhibition of synthesized
compounds ranged from 11.1 ± 0.3 to 26.2 ± 0.4 for various
bacterial strains and from 11.9 ± 0.3 to 27.2 ± 0.4 for fungal
strains. The MBC/MFC of the synthesized compounds was
two or three or four fold higher than the correspondingMIC re-
sults. Further, it was found that the nature of substituent has a
strong inﬂuence on the extent of antibacterial and antifungal
activities. The data analysis revealed that all the compounds
have produced a marked enhancement in the potency of these
analogues as antibacterial and antifungal agents.Acknowledgement
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